SUPPLEMENTARY DATA Supplementary Figure 1

SUPPLEMENTARY DATA Supplementary Figure 1

SUPPLEMENTARY DATA Supplementary Figure 1. Flowchart of study population. IA Negative: individuals who were never persistently positive for any islet autoantibody; IA Positive: individuals who had one or more persistently positive islet autoantibodies; Type 1 diabetes: diagnosed by ADA criteria between 1994 and 2011; AbPos: Antibody positive group; T1D: type 1 diabetes group. ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA Supplementary Figure 2. Description of Repeated Optimization for Feature Interpretation with Posterior Probability Product (ROFI-P3) Algorithm. ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA Supplementary Figure 3. Average Area Under the Receiver Operating Characteristic Curve (AUC) based on 5-fold cross-validation repeated 100 times for each data source and machine learning classification method. Outlined by a box are the maximum average AUC values selected for each of the six datasets across seven machine learning algorithms for two disease stages: (A) seroconversion and (B) progression to diabetes. This was the optimal machine learning algorithm. Methods used: RF: Random Forest; KNN: K-Nearest Neighbors; LDA: Linear Discriminant Analysis; LR: Logistic Regression; SVM (RBF): Support Vector Machine with a radial basis function kernel, SVM (LIN): SVM with a linear kernel; and NB: Naïve Bayes. ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA Supplementary Figure 4. Number of features from each data stream retained at 50% selection for (A) Development of IA and (B) Progression from IA to diabetes Data Stream Data Data Stream Data ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA Supplementary Table 1. Raw data for age and islet autoantibody status for control, islet autoantibody positive (AbPos) and type 1 diabetes (T1D) groups. Age and islet autoantibody status (1=positive, 0=negative) are given for each time point. Serum autoantibodies were measured for insulin (IAA), glutamic acid decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A) and zinc transporter 8 (ZnT8A). Group randomID Timepoint Age (years) GADA IA-2A IAA ZnT8A Control 11010 T1 0.8 0 0 0 T2 3.0 0 0 0 T3 6.0 0 0 0 T4 12.0 0 0 0 Last 19.0 0 0 0 Control 13063 T1 0.8 0 0 0 T2 2.3 0 0 0 T3 4.3 0 0 0 T4/Last 6.8 0 0 0 0 Control 21580 T1 0.7 0 0 0 T2 7.5 0 0 0 T3 9.3 0 0 0 T4/Last 13.4 0 0 0 Control 21645 T1 0.7 0 0 0 T2 3.0 0 0 0 T3 5.2 0 0 0 T4/Last 8.2 0 0 0 0 ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA Control 24684 T1 0.8 0 0 0 T2 2.1 0 0 0 T3 9.1 0 0 0 T4 12.1 0 0 0 Last 18.8 0 0 0 Control 28102 T1 0.7 0 0 0 T2 4.2 0 0 0 T3 7.6 0 0 0 T4/Last 16.1 0 0 0 Control 28410 T1 1.9 0 0 0 T2 5.1 0 0 0 T3 6.1 0 0 0 T4 7.2 0 0 0 0 Last 14.0 0 0 0 Control 31888 T1 0.7 0 0 0 T2 4.3 0 0 0 T3 6.3 0 0 0 T4 11.8 0 0 0 Last 19.2 0 0 0 Control 35055 T1 0.7 0 0 0 T2 3.0 0 0 0 ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA T3 8.0 0 0 0 T4 16.0 0 0 0 Last 18.9 0 0 0 Control 38964 T1 0.8 0 0 0 T2 1.3 0 0 0 T3 2.1 0 0 0 T4 11.1 0 0 0 Last 18.5 0 0 0 Control 44935 T1 0.8 0 0 0 T2 2.0 0 0 0 T3 4.2 0 0 0 T4 6.9 0 0 0 Last 12.8 0 0 0 Control 51884 T1 1.2 0 0 0 T2 2.0 0 0 0 T3 3.1 0 0 0 T4/Last 4.1 0 0 0 0 Control 54642 T1 0.7 0 0 0 T2 2.0 0 0 0 T3 4.0 0 0 0 T4/Last 8.8 0 0 0 0 Control 57003 ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA T1 1.3 0 0 0 T2 5.4 0 0 0 T3 11.5 0 0 0 T4 15.5 0 0 0 Last 17.5 0 0 0 0 Control 57732 T1 0.8 0 0 0 T2 1.3 0 0 0 T3 2.1 0 0 0 T4 3.1 0 0 0 0 Last 9.2 0 0 0 Control 61032 T1 0.9 0 0 0 T2 1.5 0 0 0 T3 2.0 0 0 0 T4 4.1 0 0 0 0 Last 16.3 0 0 0 Control 62568 T1 2.0 0 0 0 T2 4.5 0 0 0 T3 6.6 0 0 0 T4 7.6 0 0 0 Last 11.8 0 0 0 0 Control 66029 T1 1.2 0 0 0 T2 3.0 0 0 0 ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA T3 7.1 0 0 0 T4 16.1 0 0 0 Last 23.0 0 0 0 Control 74515 T1 0.8 0 0 0 T2 3.2 0 0 0 T3 6.5 0 0 0 T4 12.1 0 0 0 Last 17.4 0 0 0 Control 81324 T1 0.7 0 0 0 T2 2.0 0 0 0 T3 4.2 0 0 0 0 T4 6.5 0 0 0 Last 14.8 0 0 0 Control 90948 T1 0.8 0 0 0 T2 6.1 0 0 0 T3 9.1 0 0 0 T4 16.0 0 0 0 Last 21.5 0 0 0 Control 92568 T1 0.8 0 0 0 T2 5.4 0 0 0 T3 8.7 0 0 0 T4 13.9 0 0 0 ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA Last 17.6 0 0 0 Control 95491 T1 0.9 0 0 0 T2 6.0 0 0 0 T3 8.0 0 0 0 T4/Last 15.0 0 0 0 Control 98695 T1 0.7 0 0 0 T2 5.1 0 0 0 T3 9.4 0 0 0 T4 15.4 0 0 0 Last 22.5 0 0 0 Control 99949 T1 0.8 0 0 0 T2 5.2 0 0 0 T3 8.2 0 0 0 T4 14.1 0 0 0 Last 18.6 0 0 0 AbPos 10929 T1 0.8 0 0 0 0 T2 4.3 0 0 0 0 IA 5.3 1 0 0 0 T3 6.6 1 0 0 0 T4 17.0 1 1 0 Last 23.4 1 1 0 0 AbPos 12712 ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA T1 1.4 0 0 0 T2 3.8 0 0 0 IA 5.8 1 0 0 T3 6.0 1 0 1 T4 6.5 1 0 1 Last 10.0 1 1 1 0 AbPos 15560 T1 0.8 0 0 0 T2 5.0 0 0 0 0 IA 6.0 0 0 1 T3 6.7 0 0 0 1 T4 8.6 1 1 1 Last 14.9 1 1 0 1 AbPos 18895 T1 0.9 0 0 0 T2 5.5 0 0 0 IA 10.1 0 1 0 1 T3 10.2 0 1 0 1 T4 12.0 1 1 0 Last 18.1 0 1 0 1 AbPos 28916 T1 1.3 0 0 0 0 T2 7.3 0 0 0 0 IA 8.3 0 0 0 1 T3 9.3 0 0 0 1 T4 15.2 1 1 0 ©2019 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1263/-/DC1 SUPPLEMENTARY DATA Last 19.9 0 1 0 1 AbPos 33999 T1 0.7 0 0 0 0 T2 3.1 0 0 0 0 IA 7.9 1 0 1 0 T3 8.1 1 0 1 0 T4 15.7 1 0 0 Last 21.6 1 0 0 0 AbPos 44628 T1 0.8 0 0 0 0 T2 2.0 0 0 0 0 IA 3.0 1 0 1 1 T3 3.1 1 0 1 1 T4 9.1 1 1 1 Last 14.2 1 1 1 1 AbPos 54078 T1 3.5 0 0 0 0 T2 5.5 0 0 0 0 IA 7.4 0 0 0 1 T3 10.3 1 0 0 0 T4 14.1 1 1 0 Last 19.9 1 1 0 0 AbPos 66191 T1 2.1 0 0 0 T2 11.0 0 0 0 0 IA 12.0 1 0 1 0 ©2019 American Diabetes Association.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    42 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us